Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5061842 | Economics Letters | 2008 | 4 Pages |
Abstract
A vector integer-valued moving average (VINMA) model is introduced. The CLS and FGLS estimators are discussed. Empirically, it is found that the spillover effect from Ericsson B to AstraZeneca is larger than that from AstraZeneca to Ericsson B.
Related Topics
Social Sciences and Humanities
Economics, Econometrics and Finance
Economics and Econometrics
Authors
A.M.M. Shahiduzzaman Quoreshi,